Inzululwazi eyintloko kaMingCeler

UGqr. Guangming Wu, PhD

UGqr Guangming Wu, unjingalwazi we-Guangzhou Bio-land Laboratory, wasebenza njengomncedisi wophando okanye emva kogqirha kwi-New England Medical Animal Centre, kwiYunivesithi yaseBrown, kwiYunivesithi yaseMissouri-Columbia, kwiYunivesithi yaseTempile School of Medicine, kunye namanye amaziko ophando aziwayo kumazwe ngamazwe. .Ngo-2004, wajoyina i-Max Planck Institute ye-Molecular Biology (MPI) eJamani, apho wasebenza kunye noProf. Hans R. Schöler (iLungu le-German National Academy of Sciences) ekuphuhliseni iimbumba zemouse kunye neendlela ze-stem cell.

UGqr. Wu usebenze kwiindlela zeemolekyuli zomntu, i-porcine, i-oocyte ye-mouse kunye ne-mouse kunye nophuhliso lokuqala lwe-embryonic, kunye nokusekwa kwe-totipotency kunye ne-pluripotency iminyaka engaphezu kwe-30, kwaye uyazi kakuhle kwiinkcubeko ezahlukeneyo ze-embryonic in vitro kunye ne-micro. ubuchule bokukhohlisa.Ungowokuqala kwaye ngoku usosayensi kuphela ukunyusa izinga lokuzalwa kweempuku ezivela kwi-teknoloji yembuyekezo ye-tetraploid ukusuka kwi-1-5% ukuya kwi-30-60% ngokuphucula, ukufezekisa ushishino lweteknoloji.Ubhale ngokubambisana amaphepha e-SCI angama-79 anempembelelo edibeneyo engaphezulu kwe-670 kunye nangaphezulu kwe-7150 yokucaphula kwaye upapashe kwiijenali eziphezulu zamazwe ngamazwe ezifana neNdalo, i-Cell stem cell, njl.

Ngegalelo lakhe elibalaseleyo kulawulo lwe-embryo, igama likaGqr. Wu liboniswa ngokusisigxina kwiMunich's Deutsches Museum, eyona myuziyam inkulu yehlabathi yezenzululwazi nobuchwepheshe.

Ngo-Agasti ka-2019, uGqr. Wu waziswa e-China njengomphandi osisigxina, yena kunye neqela lakhe lophando bakha ngempumelelo imodeli yempuku ye-ACE2 phakathi kweentsuku ezingama-35, babeka "isiseko" sovavanyo lophando lwe-COVID-19 pathogenesis, ukuhlolwa kwamachiza, kunye nophuhliso lwesitofu sokugonya.Ngenxa yempumelelo yakhe eqaqambileyo kwisayensi nakwitekhnoloji, uGqr. Wu wawongwa "ngoMntu oPhezulu ekulweni ne-COVID-19 kwiPhondo laseGuangdong" ngo-2020.

Uphuhliso oluyimpumelelo nokusetyenziswa kobona buchwepheshe buphambili besizukulwana esilandelayo seTetraploid (iteknoloji yeTurboMice™) kumzekelo wempuku ngexesha lomlo ochasene ne-COVID-19, khuthaza uGqr. Wu ukuba azabalazele ixabiso elikhulu kuphuhliso lwebiopharmaceuticals.Ke ngoko, waseka i-Guangzhou MingCeler Biotech Co., Ltd njengenzululwazi eyintloko, ezinikele ekuguquleni itekhnoloji yeTurboMice ™ ukusuka kwibhubhoratri ukuya kwizicelo zoshishino ukubonelela ngeemveliso zeempuku ezikumgangatho ophezulu kunye neenkonzo kwiiyunivesithi zehlabathi, amaziko ophando, izibhedlele, kunye neenkampani zamachiza ezithatha inxaxheba kuphando lwempilo yobomi.